The preclinical market peaked in 2008, and started to decline afterward. We estimate the market size in 2015 was almost same as 2010 or even below.
Most players are dedicated to the preclinical services. While local players such as SNBL and Ina Research still show significant presence in Japan, global firms such as Charles River and Harlan have been showing prominence gradually over the years.
We estimate the market size would remain flat or slightly decrease over the years. While local firms barely hold on in the mean time, we anticipate global firms will take the leading role in the long run, with wider regional reach and service offerings.
Most players are dedicated to the preclinical services. While local players such as SNBL and Ina Research still show significant presence in Japan, global firms such as Charles River and Harlan have been showing prominence gradually over the years.
We estimate the market size would remain flat or slightly decrease over the years. While local firms barely hold on in the mean time, we anticipate global firms will take the leading role in the long run, with wider regional reach and service offerings.
